Gardasil, the vaccine that supposedly protects young girls from the human papillomavirus and the cervical cancer which it can lead to, has come under intense scrutiny from medical professionals around the world over the past few years. Unfortunately, mainstream media outlets rarely if ever share information related to this scrutiny, despite the many eye-opening revelations which have made their way into the public domain.
This is why I commonly write about the HPV vaccine and continue to push this information; because it’s not really openly discussed, but should be.
One of these revelations comes from Dr. Dianne Harper, one of a select few specialists in OB/GYN (in the world) who helped design and carry out the Phase II and Phase III safety and effectiveness studies to get Gardasil approved. There are only 50 HPV experts in the world, and Dr. Harper is one of them, inarguably making her an expert on the subject.
Since Harper’s involvement in getting Gardasil approved, she has condemned the vaccine, stating that it is neither safe nor effective. She has mentioned that the tested length of the efficacy of the vaccines in preventing HPV infection is not long enough to prevent cervical cancer, which, as she states, can take decades to develop. She has also stated that vaccination will not decrease the number of cervical cancer cases, but a routine of regular pap smears will.
Of all the women who get an HPV infection, approximately 70 percent of those will clear that infection all by themselves in the first year. You don’t even have to detect it or treat it. Within two years, approximately 90 percent of those women will clear it all by themselves. By three years, you will have 10 percent of that original group of women left who still have an HPV infection, and 5 percent of this 10 percent will have progressed into a pre-cancerous lesion. So, “now you have that small group of women who have pre-cancerous lesions and now let’s look at that moving into invasive carcinoma. What we know then is that amongst women with. . . [pre-cancerous] lesions. . . it takes five years for about twenty percent of them to become invasive carcinomas. That’s a pretty slow process. It takes about thirty years for forty percent of them to become invasive cervical carcinomas.” (source)
This begs the question, why do nine-year old girls need vaccinations for symptomless venereal diseases that their immune systems kill anyway?
Harper has told CBS that these vaccines are essentially useless, explaining that “the benefit to public health is nothing, there is no reduction in cervical cancers, they are just postponed, unless the protection lasts for at least 15 years, and over 70% of all sexually active females of all ages are vaccinated.”
She also goes on to caution of their dangers:
Parents and women must know that deaths occurred. Not all deaths that have been reported were represented in Dr. Slade’s work, one-third of the death reports were unavailable to the CDC, leaving the parents of the deceased teenagers in despair that the CDC is ignoring the very rare but real occurrences that need not have happened if parents were given information stating that there are real, but small risks of death surrounding the administration of Gardasil.
“It is a vaccine that’s been highly marketed, the benefits are over-hyped, and the dangers are underestimated.” – Dr. Chris Shaw, Professor at the University of British Columbia, in the department of Neuroscience, Ophthalmology, and Visual Sciences (Taken from the One More Girl documentary)
“When one looks at the independent literature, so studies which are not sponsored by the vaccine manufacturers, so with relation to Gardasil there have been several reports documenting multiple sclerosis and encephalitis, which is brain inflammation, in girls who have received their Gardasil vaccine. So just because a study sponsored by the manufacturers does not identify problems with the vaccine does not necessarily mean that the vaccine is safe. In fact if one looks at the manufacturer studies, they’re often not designed to detect serious adverse events. There was a study done by a group of researchers sponsored by Glaxo Smith and Kline and they were looking at Cervarix, which is another HPV vaccine, and the authors acknowledged that none of the studies that they evaluated have been designed to detect autoimmune diseases. So obviously, you’re not going to find what you’re not looking for. And in spite of these obvious flaws, they concluded that there is no evidence that Cervarix is associated with increased risk for autoimmune diseases, and this is absurd because you haven’t looked for it, the study has not been designed to detect autoimmune diseases.”
– Dr. Lucija Tomljenovic, PhD, Post-doctoral Fellow at the University of British Columbia, where she works in Neurosciences and the Department of Medicine (source)
Brand New Study Outlines Why Many Doctors Don’t Recommend HPV Shots
A brand new study recently published in the journal Pediatrics has found that many paediatricians don’t strongly recommend the HPV vaccine. For those of you who are unaware, the HPV vaccine, also known as the Gardasil vaccine, is designed to protect against four types of human papillomavirus, or HPV. Although the HPV vaccine is banned in multiple countries, like Japan for example, it has been approved for use in Canada and approximately 100 other countries.
Researchers used a national survey asking approximately 600 doctors to outline their stance on the HPV vaccine. Conducted between October 2013 and January 2014, the study found that a large percentage of paediatricians and family doctors — nearly one third of those surveyed — are not strongly recommending the HPV vaccine to parents and preteens, which is why, as illustrated by the study, HPV vaccination rates continue to drop.
The study mentioned that some doctors felt the need for a clearer understanding of reasons to vaccinate preteens, particularly given the fact that most do not become sexually active until later on in life, and that many parents would object to them assuming otherwise.
Prior to this, another study was published in the journal Cancer Epidemiolog in 2015. Written by Melissa B. Gilkey, an assistant professor at Harvard Medical School, the study was designed to assess how physicians recommend the HPV vaccine. The authors were surprised to find that “physicians so often reported recommending HPV vaccination inconsistently, behind schedule, or without urgency. Of the five communication practices we assessed, about half of physicians reported two or more practices that likely discourage timely HPV vaccination.” (source)
This study found that 27 percent of physicians across the United States do not strongly endorse HPV vaccination, and 39 percent reported that they do not give the vaccinations on time as recommended. Approximately 59 percent of physicians recommended it for adolescents.
Physicians questioning vaccine safety seems to be a growing trend, and this is evident and expressed in multiple publications. For example, a fairly recent study published in the journal Human Vaccines & Immunotherapeutics emphasized that “more research is needed to understand why some health professionals, trained in medical sciences, still have doubts regarding the safety and effectiveness of vaccination.” (source)
A new study published in the journal EbioMedicine outlines how more and more physicians, more specifically those in France, do not follow the recommended vaccination schedule and have hesitancy with regards to vaccination for a number of reasons, mainly due to a lack of trust in pharmaceutical grade products, their perception of the utility and risks of vaccines, and their comfort in explaining them to patients. (source)
American College of Pediatricians Links HPV Vaccine (Gardasil) To “Very Rare But Serious Condition.”
“It has recently come to the attention of the College that one of the recommended vaccines could possibly be associated with the very rare but serious condition of premature ovarian failure (POF), also known as premature menopause. There have been two case report series (3 cases each) published since 2013 in which post-menarcheal adolescent girls developed laboratory documented POF within weeks to several years of receiving Gardasil, a four-strain human papillomavirus vaccine (HPV4).”
The press release goes on to state that adverse reactions are not commonly caused by the vaccine, and that there has not been a noticeable rise in POF cases in the last 9 years that the vaccine has been widely used. This is not the first time a statement from a government medical agency has contradicted the evidence of various scientists and doctors around the world. Nevertheless, it’s great to see them at least acknowledge these potentials, stating that there are “legitimate concerns that should be addressed.” These concerns, according to them, are as follows:
- Long term ovarian function was not assessed in either the original rat safety studies, or in the human vaccine trial
- Most primary care physicians are probably unaware of a possible association between HPV4 and POF and may not consider reporting POF cases or prolonged missing menstrual periods to the Vaccine Adverse Event Reporting System (VAERS)
- Potential mechanisms of action have been postulated based on autoimmune associations with the aluminum adjuvant used and previously documented ovarian toxicity in rats from another component, polysorbate 80
- Since licensure of Gardasil in 2006, there have been about 213 VAERS reports involving amenorrhea, POF or premature menopause, 88 percent of which have been associated with Gardasil
“The overwhelming majority (76%) of VAERS reports since 2006 with ovarian failure, premature menopause, and/or amenorrhea are associated solely with Gardasil. . . . A Vaccine Safety Datalink POF study is planned to address an association between these vaccines and POF, but it may be years before results will be determined. Plus, POF within a few years of vaccination could be the tip of the iceberg since ovarian dysfunction manifested by months of amenorrhea may later progress to POF.”
It’s also worth mentioning that more than a dozen girls recently came forward in Europe claiming that they are suffering from acute physical side effects from the HPV vaccine. You can read more about that here.
Concordia Professor Criticizes HPV Vaccine After Winning A Federal Grant To Study It
Dr. Genevieve Rail, Professor of Critical Studies of Health at Concordia University, recently received a grant of $270,000 from the Canadian Institute for Health Research (CIHR) to study the Human Papillomavirus (HPV). She concluded that there is absolutely no proof that the human papillomavirus directly causes cervical cancer.
“I’m sort of raising a red flag, out of respect for what I’ve found in my own study, and for the despair of parents who had totally perfect 12-year-olds who are now in their beds, too tired to go to school,” she said. “Yes, we’re going against the grain, and we are going against those who are believed, i.e. doctors and nurses and people in public health.” (source)